Grid box-level evaluation of IMERG over Brazil at various space and time scales

This study evaluates the performance of the Integrated Multi-satellitE Retrievals for GPM (IMERG) Final Run product over Brazil by means of multi-temporal and -spatial analyses. The assessment of the IMERG Final Run product is based on six statistics obtained for the period between January-December 2016 (daily, monthly, and annual basis). The analysis consisted of comparing the satellite-based estimates against a ground-based gridded rainfall product created using daily records from 4,911 rain gauges distributed throughout Brazil. Overall, the results show that the IMERG product can effectively capture the spatial patterns of rainfall across Brazil. However, the IMERG product presents a slight tendency in overestimating the ground-based rainfall at all timescales. Furthermore, the performance of the satellite product varies throughout the region. The higher errors and biases are found in the North and Central-West regions, but the low density of rain gauges in those regions can be a source of large deviations between IMERG estimates and observations. A large underestimation of the IMERG data is evident along the coastal zone of the Northeast region, probably due to the inability of the passive microwave and infrared sensors to detect warm-rain processes over land. This study shows that the IMERG product can be a good source of rainfall data to complement the ground precipitation measurements in most of Brazil, although some uncertainties are found and need to be further studied

Metronidazole thermogel improves retention and decreases permeation through the skin

ABSTRACT Metronidazole (MTZ) is widely used as the standard antibiotic for the treatment of rosacea and, more recently, is being used off label in Brazilian hospitals for the treatment of wounds. Following oral administration, minimal amounts of active agent reaches the skin and side effects are strongly induced. Consequently, MTZ is currently being applied topically in order to improve the therapeutic efficacy with reduced side effects, with Rozex(r) (RZ) (an MTZ gelled formulation) being the only marketed product. This study examined whether the use of MTZ 0.75% from thermogel formulations could improve drug retention and reduce dermal exposure compared to that by Rozex(r). Following a 21 h permeation study, the highest total amount of MTZ permeated through the rat healthy and disturbed skin was seen with Rozex(r), but similar to all formulations regardless of the skin condition. On the other hand, the amount retained in the epidermis/dermis was larger for thermogel formulations; at least 4 fold that of Rozex(r), when the stratum corneum was present as a barrier. In conclusion, thermogel formulations can be favorable alternatives to Rozex(r) for the topical application of MTZ with improved efficacy and reduced side effects